November 17, 2026
Daily Market Report

Mid-Morning Look: November 17, 2026

Mid-Morning Look

Tuesday, November 17, 2026

Index

Up/Down

%

Last

DJ Industrials

-439.33

0.85%

51,168

S&P 500

-49.66

0.67%

7,366

Nasdaq

-192.43

0.79%

24,317

Russell 2000

-17.01

0.62%

2,725

 

 

U.S. stocks have round-tripped since the open, with the Dow, S&P 500 and Nasdaq all reversing from its overnight futures gain to trade down as investor sentiment remains cautious ahead of NVDA earnings tonight and the Anthropic IPO mid-week. Investors cut their overweight to tech stocks by the most since 2006 in the latest Bank of America Global Fund Manager Survey. Bank of America’s November fund manager survey shows a sharp increase in expectations for an Ai spending slowdown; 52% expect a major Ai hyperscaler to announce a capital expenditure cut within six months, up from 30% in October, while 40% do not anticipate such a reduction. The shift highlights growing investor concerns about the sustainability of Ai infrastructure spending and potential pressure on technology stocks. A very busy morning of economic data as well, including mush weaker housing data and industrial production, while both export and import top consensus and retail sales were in-line with economist expectations. Energy (XLE) and Materials (XLB) early leaders while tech (XLK) again leads to the downside.

 

President Trump landed in Manila, kicking off his Asian tour with a Quad summit focused on economic security and countering Beijing’s influence before talks with Xi; Trump, Xi and Putin are due to meet at the APEC summit. President Trump also dismissed concerns over recent disruptions affecting Microsoft, JPMorgan Chase and U.S. Aviation systems. The incidents included a global Microsoft outage, an FAA Equipment failure that grounded flights for more than four hours, and Banking transaction delays. Speaking in Manila, Trump said the disruptions were under control and Assured Americans that travel remains safe ahead of Thanksgiving. The Euro falls to 19-month lows of $1.0982 as the dollar extends gains, while Treasury yields hold steady after a rip the last few days.

 

Ahead of NVDA earnings tonight, several items in the news again today: 1) NVDA warns customers of potential legal exposure under new offshore chip-access restrictions; will halt sales to data centers renting over 50% of their GPUs to Chinese firms, per CNBC; the company said it establishes a standing board committee overseeing national security, export compliance and global trade risk, alongside enhancements to internal compliance teams; 3) late yesterday the NVDA board said it is not considering reinstating Jensen Huang as CEO. This week also brings more AI headlines including the Anthropic IPO (Bloomberg reports likely to price IPO above current range of $70-$78) and also says has drawn multiple orders of $10B or more, and also November options expiry on Friday.

Economic Data

  • Oct retail sales rose +0.2%, in line with consensus +0.2%, while U.S. Oct Retail Sales Ex-autos +0.6% (above the consensus +0.4%) but below the September +1.1%; Excluding gas and autos, retail sales grew 0.5% M/M vs. +0.3% consensus and +0.5% prior (revised from +0.2%). miscellaneous store retailers posted the biggest increase, rising 4.7%, more than offsetting a 3.0% M/M decrease in September.
  • U.S. export prices rose 1.1% M/M in October vs. +0.3% consensus and +2.4% prior (revised from +2.2%); Import prices increased 1.1% M/M vs. +0.7% consensus and +1.1% in September. Higher prices for nonfuel imports drove the rise in October. U.S. Oct Petroleum import prices +3.7% vs Sept +6.2%.
  • Oct Industrial output declined -0.4% (vs. consensus +0.1%) and below the Sept +0.7%; Oct mining output fell -0.8% (vs. Sept -0.2%), Utilities output -4.3% (Sept +4.4%). Capacity Utilization use rate 76.4% (below consensus 76.8%) vs Sept 76.8% (previous 76.9%). Oct industrial output ex cars/parts -0.7% vs Sept +0.9%.
  • U.S. Sept Business Inventories +0.5%, in-line with consensus +0.5% and vs Aug +0.4%; Sept inventory/sales ratio 1.33 months’ worth vs Aug 1.35 months; U.S. Sept business sales +1.8% vs Aug +1.2% (prev +1.1%). U.S. Sept retail inventories ex-autos revised to +0.5% (prev +0.4%).
  • U.S. November NAHB Housing market index 25, lowest level since 2012 and vs. consensus 29 and 29 in October (previous 29); November index of current single-family home sales 28 versus revised 34 in October (previous 33); November index of home sales over next six months 30 versus 32 in October (previous 32).

 

 

Macro

Up/Down

Last

WTI Crude

0.79

86.51

Brent

0.75

93.19

Gold

16.30

3,869.30

EUR/USD

0.0004

1.100

JPY/USD

-0.101

159.29

10-Year Note

0.018

5.14%

 

Sector Movers Today

  • Managed Care sector (ELV, CI, UNH, HUM) stocks under pressure after the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs, including Medicare, Medicaid, and the Health Insurance Marketplace. The proposed rule titled the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) is expected to save U.S. taxpayers nearly $90B over the next 10 years, the Centers for Medicare & Medicaid Services said in a statement. CRUSH would increase fraud reporting requirements for Medicare Advantage firms and Part D plan sponsors.
  • Optical sector (AAOI, CIEN, GLW, COHR, LITE) rise as the U.S. moves ahead with Chinese data center equipment restrictions despite big tech opposition. The FCC is seeking to block imports of new Chinese optical transceiver models over national security concerns, Reuters reports. Amazon, Google, Meta, Microsoft, CoreWeave and Cisco warned the White House that compliance could take up to 10 years.
  • Software sector broadly lower with aggressive pullbacks in shares of CRM, DDOG, FIG, MNDY, MDB, NOW, OKTA, TEAM , WDAY and many others – some speculating further source of funds selling ahead of the Anthropic IPO coming this week. Also Cleveland Research had cautious comments on both CRM and WDAY saying for CRM, said Q3 appeared in line but feedback softer vs prior (and JPM said Third-Party Surveys Point to Ai adoption hitting real-world challenges, even though disruption risk is limited), while for WDAY, says Q3 finished below partner plan.

 

Stock GAINERS

  • ACM +10%; after posts Q4 revenue and adj. EPS of $3.88B and $1.63, respectively, beating analysts’ ests of $1.93B and $1.58 on record backlog growth of 13%; results were driven by record project wins, backlog growth, strong margins and robust demand for advisory services; guides year EPS $6.15-$6.35 vs. est. $6.19
  • AS +8%; shares rise on earnings beat after Q3 adj EPS $0.42 vs. est. $0.35; Q3 revs rose 24% y/y to $2.17B vs. est. $2.14B; said all segments, geographies, and channels achieved double-digit growth; raises FY26 EPS view to $1.32-$1.35 from $1.27-$1.30 and boosts FY26 revenue growth to 25%-26%.
  • COHR +3%; along with gains in other optical stocks AAOI after the U.S. moves ahead with Chinese data center equipment restrictions despite big tech opposition.
  • DIS +2%; posted a top and bottom line beat with Q4 adj EPS $1.77 vs. est. $1.67 and revs rose 16% y/y to $25.95B vs. est. $25.18B and said it expects double-digit growth in adj EPS in FY27, ex: the impact of the extra week, adding that it expects the majority of the growth to occur in the first half of the year; said it would boost cash content spending to $26B next year; raises dividend by 33% and targets $9B in buybacks.
  • NKE +3%; holding its first Investor Day in roughly a decade today, outlined its FY31 financial framework, with the outlook pointing to adjusted EPS of $3 to $3.50 on a 12%-14% operating margin, above Stifel expectations for an 11% EBIT margin and $3 EPS despite lower revenue.
  • SITE +5%; will replace ITGR in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, November 19
  • SLS +163%; as announced positive pivotal phase 3 regal trial data showing immunotherapeutic cancer vaccine, galinpepimut-s (GPS), demonstrated a statistically significant and clinically meaningful improvement in overall survival in patients with acute myeloid leukemia.

 

Stock LAGGARDS

  • CRM -7%; amid an aggressive selloff in software space this morning (HUBS, TEAM, WDAY, MDB).
  • DB -3%; after a series of media reports based on leaked documents detailed the lender’s internal deliberations and handling of more than a decade’s worth of missteps and scandals. A media consortium reported on failings in the bank’s handling of high-risk customers.
  • OMER -18%; shares fell after Q3 revs $36M missed the $37.3M consensus while adj EPS $0.06 above est. $0.02; said growth in sales of Yartemlea, OMER’s drug for treating stem cell transplant-related blood vessel damage, was partly offset by increased participation in 340B program.
  • PEP -2%; was downgraded to Underperform at Bernstein and trimmed tgt to $128 from $131 citing persistent weakness in North America, where it expects both the snacks and beverages businesses to continue losing volume and market share.
  • RCAT -31%; as Q3 earnings results materially missed expectations because of funding delays and the Gauntlet II outcome, prompting withdrawal of full-year guidance; reported Q3 EPS loss (-$0.26) vs. est. (-$0.19) and revenue $11.8Mm vs. est. $39.5Mm, up 22% Y/Y; operating loss $43.4Mm.
  • UNH -3%; along with weakness in HUM, CNC, ELV in managed care after the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs.
  • VIK -1%; Q3 EPS and revs both fell short of consensus at $1.11 adj EPS vs. estimate $1.27 and revs rose 9% y/y to $2.18B but just below est. $2.2B; noted Q3 net income fell y/y to $498.37M; Advance bookings for the 2027 season climbed 17% versus the prior season’s comparable point

_________________________________________________________________

Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.